| Literature DB >> 15675041 |
Ju-Hong Jeon1, Hye-Jin Lee, Gi-Yong Jang, Chai-Wan Kim, Dong-Myung Shim, Sung-Yup Cho, Eui-Ju Yeo, Sang-Chul Park, In-Gyu Kim.
Abstract
The treatment of cystamine, a transglutaminase(TGase) inhibitor, has beneficial effects in several diseases including CAG-expansion disorders and cataract. We compared the inhibition characteristics of cystamine with those of cysteamine, a reduced form of cystamine expect-ed to be present inside cells. Cystamine is a more potent inhibitor for TGase than cysteamine with different kinetics pattern in a non-reducing condition. By contrast, under reducing conditions, the inhibitory effect of cystamine was comparable with that of cysteamine. How-ever, cystamine inhibited intracellular TGase activity more strongly than cysteamine despite of cytoplasmic reducing environment, suggest-ing that cystamine itself inhibits in situ TGase activity by forming mixed disulfides.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15675041 DOI: 10.1038/emm.2004.74
Source DB: PubMed Journal: Exp Mol Med ISSN: 1226-3613 Impact factor: 8.718